Renaissance Capital logo

Biotech CardioMEMS withdraws IPO

May 7, 2007

CardioMEMS, which develops miniature wireless sensors to monitor chronic cardiovascular diseases, withdrew its filing for IPO on Friday, citing market conditions. The company had originally filed for IPO on January 19, and Banc of America was the lead manager on the deal.